No Data
Lake Street Maintains NeuroPace(NPCE.US) With Buy Rating, Maintains Target Price $20
Lake Street analyst Frank Takkinen maintains $NeuroPace(NPCE.US)$ with a buy rating, and maintains the target price at $20.According to TipRanks data, the analyst has a success rate of 46.9% and a
NeuroPace (NPCE) Gets a Buy From Lake Street
Press Release: NeuroPace Strengthens Management Team With Two Key Appointments
NeuroPace to Participate in Upcoming Healthcare Conferences in September
NeuroPace Second Quarter 2024 Earnings: Beats Expectations
Earnings Release: Here's Why Analysts Cut Their NeuroPace, Inc. (NASDAQ:NPCE) Price Target To US$14.57